Domain Therapeutics domaintherapeutics.com


Public list: BIO 2016 (619) Pharma Startups (4732)

Domain Therapeutics, formerly Faust Pharmaceuticals, is a biopharmaceutical company dedicated to the discovery and early development of small molecules targeting G-Protein Coupled Receptors (GPCRs). Domain Therapeutics discovers allosteric modulators by exploiting its DTect-All technology. The company's pipeline is composed of new chemical entities, ranging from hits to optimized leads for significant indications such as schizophrenia, Parkinson's disease and diabetes.

Domain Therapeutics, formerly Faust Pharmaceuticals, is a biopharmaceutical company dedicated to the discovery and early development of small molecules targeting G-Protein Coupled Receptors (GPCRs). Domain Therapeutics discovers allosteric modulators...Show all

Company (Alive / Active)

Phone: +33 3 90 40 61 50

Fax:

Bioparc
850 Boulevard S├ębastien Brant
Illkirch-Strasbourg, 67400
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Domain Therapeutics $39.1M Apr 14, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Domain Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 15 investors
There is no Competitors data available for this company. Please select another tab.